Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studyJoëlle Vermeulen, Jo Vandesompele, Jan Hellemans et al.|The Lancet Oncology|2009Cited by 196
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Rebekah Weston, Cormac Owens et al.|Journal of Clinical Oncology|2024Cited by 25
Title Page / Table of ContentsJoris Vermeesch, Bernard Thienpont, Stefan J. White et al.|Cytogenetic and Genome Research|2006Cited by 0